Zou W, Regulatory T. Cells, tumour immunity and immunotherapy. Nat Rev Immunol. 2006;6(4):295–307.

Article  CAS  PubMed  Google Scholar 

Dikiy S, Rudensky AY. Principles of regulatory T cell function. Immunity. 2023;56(2):240–55.

Article  CAS  PubMed  Google Scholar 

Li C, Jiang P, Wei S, Xu X, Wang J. Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects. Mol Cancer. 2020;19(1):116.

Article  PubMed Central  PubMed  Google Scholar 

Sun L, Su Y, Jiao A, Wang X, Zhang B. T cells in health and disease. Signal Transduct Target Therapy. 2023;8(1):235.

Article  CAS  Google Scholar 

Morad G, Helmink BA, Sharma P, Wargo JA. Hallmarks of response, resistance, and toxicity to immune checkpoint blockade. Cell. 2021;184(21):5309–37.

Article  CAS  PubMed Central  PubMed  Google Scholar 

Zheng X, Hou Z, Qian Y, Zhang Y, Cui Q, Wang X, et al. Tumors evade immune cytotoxicity by altering the surface topology of NK cells. Nat Immunol. 2023;24(5):802–13.

Article  CAS  PubMed  Google Scholar 

Huo JL, Wang YT, Fu WJ, Lu N, Liu ZS. The promising immune checkpoint LAG-3 in cancer immunotherapy: from basic research to clinical application. Front Immunol. 2022;13:956090.

Article  CAS  PubMed Central  PubMed  Google Scholar 

de Miguel M, Calvo E. Clinical challenges of Immune Checkpoint inhibitors. Cancer Cell. 2020;38(3):326–33.

Article  PubMed  Google Scholar 

Seidel JA, Otsuka A, Kabashima K. Anti-PD-1 and Anti-CTLA-4 therapies in Cancer: mechanisms of Action, Efficacy, and limitations. Front Oncol. 2018;8:86.

Article  PubMed Central  PubMed  Google Scholar 

Carlino MS, Larkin J, Long GV. Immune checkpoint inhibitors in melanoma. Lancet (London England). 2021;398(10304):1002–14.

Article  CAS  PubMed  Google Scholar 

Lin EP, Hsu CY, Berry L, Bunn P, Shyr Y. Analysis of Cancer Survival Associated with Immune checkpoint inhibitors after Statistical Adjustment: a systematic review and Meta-analyses. JAMA Netw open. 2022;5(8):e2227211.

Article  PubMed Central  PubMed  Google Scholar 

Garassino MC, Gadgeel S, Speranza G, Felip E, Esteban E, Dómine M, et al. Pembrolizumab Plus Pemetrexed and Platinum in Nonsquamous Non-small-cell Lung Cancer: 5-Year outcomes from the phase 3 KEYNOTE-189 study. J Clin Oncol. 2023;41(11):1992–8.

Article  CAS  PubMed Central  PubMed  Google Scholar 

Sharma P, Hu-Lieskovan S, Wargo JA, Ribas A. Primary, adaptive, and Acquired Resistance to Cancer Immunotherapy. Cell. 2017;168(4):707–23.

Article  CAS  PubMed Central  PubMed  Google Scholar 

Kumar P, Saini S, Prabhakar BS. Cancer immunotherapy with check point inhibitor can cause autoimmune adverse events due to loss of Treg homeostasis. Semin Cancer Biol. 2020;64:29–35.

Article  PubMed  Google Scholar 

Savage PA, Klawon DEJ, Miller CH. Regulatory T Cell Development. Annu Rev Immunol. 2020;38:421–53.

Article  CAS  PubMed  Google Scholar 

Sakaguchi S, Mikami N, Wing JB, Tanaka A, Ichiyama K, Ohkura N. Regulatory T cells and human disease. Annu Rev Immunol. 2020;38:541–66.

Article  CAS  PubMed  Google Scholar 

Raffin C, Vo LT, Bluestone JA. T(reg) cell-based therapies: challenges and perspectives. Nat Rev Immunol. 2020;20(3):158–72.

Article  CAS  PubMed  Google Scholar 

Hippen KL, Hefazi M, Larson JH, Blazar BR. Emerging translational strategies and challenges for enhancing regulatory T cell therapy for graft-versus-host disease. Front Immunol. 2022;13:926550.

Article  CAS  PubMed Central  PubMed  Google Scholar 

Ohkura N, Sakaguchi S. Transcriptional and epigenetic basis of Treg cell development and function: its genetic anomalies or variations in autoimmune diseases. Cell Res. 2020;30(6):465–74.

Article  CAS  PubMed Central  PubMed  Google Scholar 

Liu Y, Yang M, Tang L, Wang F, Huang S, Liu S, et al. TLR4 regulates RORγt(+) regulatory T-cell responses and susceptibility to colon inflammation through interaction with Akkermansia muciniphila. Microbiome. 2022;10(1):98.

Article  CAS  PubMed Central  PubMed  Google Scholar 

Dong Y, Yang C, Pan F. Post-translational regulations of Foxp3 in Treg Cells and their therapeutic applications. Front Immunol. 2021;12:626172.

Article  CAS  PubMed Central  PubMed  Google Scholar 

Cheru N, Hafler DA, Sumida TS. Regulatory T cells in peripheral tissue tolerance and diseases. Front Immunol. 2023;14:1154575.

Article  CAS  PubMed Central  PubMed  Google Scholar 

Shao Q, Gu J, Zhou J, Wang Q, Li X, Deng Z, et al. Tissue tregs and maintenance of tissue homeostasis. Front Cell Dev Biol. 2021;9:717903.

Article  PubMed Central  PubMed  Google Scholar 

Shakhar G, Lindquist RL, Skokos D, Dudziak D, Huang JH, Nussenzweig MC, et al. Stable T cell-dendritic cell interactions precede the development of both tolerance and immunity in vivo. Nat Immunol. 2005;6(7):707–14.

Article  CAS  PubMed Central  PubMed  Google Scholar 

Xiao Y, Yu D. Tumor microenvironment as a therapeutic target in cancer. Pharmacol Ther. 2021;221:107753.

Article  CAS  PubMed  Google Scholar 

Tanaka A, Sakaguchi S. Regulatory T cells in cancer immunotherapy. Cell Res. 2017;27(1):109–18.

Article  CAS  PubMed  Google Scholar 

Palucka K, Banchereau J. Cancer immunotherapy via dendritic cells. Nat Rev Cancer. 2012;12(4):265–77.

Article  CAS  PubMed Central  PubMed  Google Scholar 

Śledzińska A, Vila de Mucha M, Bergerhoff K, Hotblack A, Demane DF, Ghorani E, et al. Regulatory T cells restrain Interleukin-2- and Blimp-1-Dependent Acquisition of cytotoxic function by CD4(+) T cells. Immunity. 2020;52(1):151–e666.

Article  PubMed Central  PubMed  Google Scholar 

Togashi Y, Shitara K, Nishikawa H. Regulatory T cells in cancer immunosuppression - implications for anticancer therapy. Nat Reviews Clin Oncol. 2019;16(6):356–71.

Article  CAS  Google Scholar 

Yan Y, Huang L, Liu Y, Yi M, Chu Q, Jiao D, et al. Metabolic profiles of regulatory T cells and their adaptations to the tumor microenvironment: implications for antitumor immunity. J Hematol Oncol. 2022;15(1):104.

Article  CAS  PubMed Central  PubMed  Google S